GO2, LLC, a client of Eva Garland Consulting, has developed a highly innovative treadling device called the CV2.  GO2 worked with EGC to submit a NIH SBIR proposal to conduct clinical trials that are expected to further demonstrate the substantial benefits of the CV2 for addressing complications of diabetes.